Probiotic Safety Assessment Experts are responsible for evaluating the safety of probiotic strains intended for use in foods, supplements, and therapeutics. They conduct comprehensive assessments to ensure that each microbial strain is non-pathogenic, does not carry transferable antibiotic resistance genes, and is free from harmful metabolites or toxins. These experts play a critical role in risk analysis, using both in vitro and in vivo studies to evaluate host-microbe interactions and potential adverse effects.
They collaborate with microbiologists, toxicologists, regulatory specialists, and product developers to validate the safety profile of probiotics before they reach the consumer. Their work includes genomic and phenotypic characterization of strains, dose-response evaluations, and post-market surveillance to detect any emerging safety concerns. Probiotic Safety Assessment Experts also contribute to the preparation of regulatory dossiers required for approvals from authorities like EFSA, FDA, or FSSAI. They help establish strain-specific safety thresholds and guide manufacturers in selecting appropriate probiotic candidates for specific populations, such as infants, the elderly, or immunocompromised individuals. Their expertise ensures that probiotic products are not only effective but also safe for long-term use. As the market expands, their work remains fundamental to building consumer confidence and upholding public health standards in probiotic innovation.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India